172@29@16@54!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Oct 19, 16:00
476.65 -14.20 (-2.89%)
Volume
AVERAGE VOLUME
5-Day
186,106
10-Day
151,224
30-Day
151,809
113,354
  • Prev. Close

    490.85

  • Open Price

    497.95

474.25

Today’s L/H

497.95
168.00

52 Wk L/H

572.70
441.80

L/U Price Band

539.90
  • Bid Price (Qty.)

    476.65 (598)

  • Offer Price (Qty.)

    480.00 (75)

  •  VWAP

    482.02
     Beta
    0.75
  • Market Depth (19 Oct 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    450 478.00 478.80 450
    374 477.90 478.90 127
    900 477.65 479.20 900
    1348 477.50 479.25 500
    599 477.40 479.30 1397
    3244 Total Total 6026
     Market Depth
    BUY 3244.00
    SELL 6026.00
    35%
    65%

NSE Live

Oct 19, 15:59
476.70 -14.20 (-2.89%)
Volume
AVERAGE VOLUME
5-Day
3,630,464
10-Day
3,253,987
30-Day
3,085,904
3,806,531
  • Prev. Close

    490.90

  • Open Price

    493.40

474.00

Today’s L/H

494.95
161.65

52 Wk L/H

573.05
441.85

L/U Price Band

539.95
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    476.70 (2586)

  •  VWAP

    482.17
     Beta
    0.81
  • DELIVERY AVERAGES
    3-Day
    15.57%
    5-Day
    15.09%
    8-Day
    17.96%
    Deliverables
  • SMA
    30
    483.73
    50
    482.81
    150
    399.02
    200
    379.11
    SMA
    483.73
Powered by Trendlyne
Parameters
NSE
BSE
Bid Price
0.00
476.65
Bid Qty
0
598
Offer Price
476.70
480.00
Offer Qty
2586
75
Today's Low
474.00
474.25
Today's High
494.95
497.95
52 Wk Low
161.65
168.00
52 Wk High
573.05
572.70
Open Price
493.40
497.95
Prev. Close
490.90
490.85
Expiry Date
478.35 -14.05 ( -2.85 % )
Parameters
NSE
Open Price
494.00
High Price
494.70
Low Price
474.20
Prev. Close
492.40
Average Price
482.37
No. of Contracts Traded
3
Turnover (Rs. In Lakhs)
35,391.49
Market Lot
2300
Open Interest
8,144,300
Open Interest Change
710,700
Open Interest Change %
9.56
Expiry Date
Option Type
Strike Price
478.35 -14.05 ( -2.85 % )
Parameters
NSE
Open Price
494.00
High Price
494.70
Low Price
474.20
Prev. Close
492.40
Average Price
482.37
No. of Contracts Traded
3
Turnover (Rs. In Lakhs)
35,391.49
Market Lot
2300
Open Interest
8,144,300
Open Interest Change
710,700
Open Interest Change %
9.56

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Bearish
Technical Indicators Neutral
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 504.57 518.23 536.02 486.78 473.12 455.33 441.67
Fibonacci 498.80 506.22 518.23 486.78 474.77 467.35 455.33
Camarilla 493.78 496.67 499.55 486.78 488.02 485.13 482.25

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 483.84
10 488.82
20 484.04
50 482.81
100 454.17
200 379.11
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 510.63 530.37 551.18 489.82 470.08 449.27 429.53
Fibonacci 505.31 514.88 530.37 489.82 474.33 464.76 449.27
Camarilla 494.62 498.33 502.05 489.82 487.18 483.47 479.75

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 520.17 557.68 596.92 480.93 443.42 404.18 366.67
Fibonacci 510.25 528.36 557.68 480.93 451.61 433.50 404.18
Camarilla 489.69 496.72 503.76 480.93 475.61 468.58 461.54

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      13,449.55
    • P/E
      8.46
    • Book Value (Rs)
      468.74
    • Dividend (%)
      250.00
    • Market Lot
      1
    • Industry P/E
      37.01
    • EPS (TTM)
      56.32
    • P/C
      7.79
    • Price/Book
      1.02
    • Dividend Yield.(%)
      0.52
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      15.57
      5-Day
      15.09
      8-Day
      17.96
      11.99

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      13,449.55
    • P/E
      14.61
    • Book Value (Rs)
      215.12
    • Dividend (%)
      250.00
    • Market Lot
      1
    • Industry P/E
      37.01
    • EPS (TTM)
      32.63
    • P/C
      10.05
    • Price/Book
      2.22
    • Dividend Yield.(%)
      0.52
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      15.57
      5-Day
      15.09
      8-Day
      17.96
      11.99

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

F&O QUOTE

NSE 478.35 -14.05 (-2.85%)
Instrument Type
Expiry Date
Option Type
Strike Price
    • Open Price
      494.00
    • High Price
      494.70
    • Low Price
      474.20
    • Prev. Close
      492.40
    • Average Price
      482.37
    • No. of Contracts Traded
      3
    • Turnover (Rs. In Lakhs)
      35,391.49
    • Market Lot
      2300

Forum

Community Sentiments

  • 80% BUY
  • 20% SELL
  • 0% HOLD
80%
of moneycontrol users recommend buying Glenmark

What's your call on Glenmark today?

Read 79 investor views

BUY SELL HOLD

Action in Glenmark Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Oct 19, 09:15
497.95 7.10 (1.45%)
High 499.80
Low 497.95
Prev. Close 490.85

NSE

Oct 19, 09:15
493.40 2.50 (0.51%)
High 493.40
Low 491.05
Prev. Close 490.90

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
2,344 2,767 2,735 2,815 2,322
Other Income
58 44 32 80 1
Total Income
2,403 2,811 2,768 2,895 2,324
Total Expenditure
1,951 2,395 2,401 2,458 2,071
EBIT
451 416 367 437 252
Interest
93 98 96 89 93
Tax
103 97 80 91 50
Net Profit
254 220 190 255 109

Historical Prices

On
Current Price %Gain / Loss
Open Price 288.90 497.95
72.36
High Price 301.20 497.95
65.32
Low Price 287.50 474.25
64.96
Close Price 299.70 490.85
63.78
Volume 81,602 113,354
38.91
On
Current Price %Gain / Loss
Open Price 290.00 493.40
70.14
High Price 301.50 494.95
64.16
Low Price 287.10 474.00
65.1
Close Price 299.85 490.90
63.72
Volume 1,927,084 3,806,531
97.53
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11873.00 110.50 0.94
SENSEX 40431.60 448.62 1.12
NIFTY BANK 24266.80 733.55 3.12
NIFTY IT 21391.90 -146.30 -0.68
S&P BSE Smallcap 14850.88 64.32 0.43
Index Price Change %Chg
Nasdaq (Oct 19) 11,669.31 -2.25 -0.02
DAX (Oct 19) 12,878.15 -30.84 -0.24
CAC (Oct 19) 4,951.10 15.24 0.31
FTSE (Oct 19) 5,898.93 -20.65 -0.35
SGX Nifty (Oct 19) 11,868.50 -40.50 -0.34

CORPORATE ACTION

Date Agenda
Aug 14, 2020 Quarterly Results
Jun 26, 2020 Audited Results & Dividend
Feb 14, 2020 Quarterly Results & Others
Nov 14, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 250.00 Sep 17, 2020
Final 200.00 Sep 19, 2019
Final 200.00 Sep 19, 2018
Final 200.00 Sep 20, 2017
Final 200.00 Aug 03, 2016
Ratio Announcement Date Ex-Bonus
1:1 Jan 06, 2005 Mar 04, 2005
Old FV New FV Ex-Split
2 1 Sep 10, 2007
10 2 Oct 23, 2003
Ratio Premium Ex-Bonus
No Rights Information is available for Glenmark Pharma
Date Agenda
Sep 29, 2020 -
Sep 27, 2019 -
Sep 27, 2018 -
Sep 28, 2018 -
Sep 29, 2017 -

Dividend Summary

For the year ending March 2020 Glenmark Pharma has declared an equity dividend of 250.00% amounting to Rs 2.5 per share. At the current share price of Rs 476.70 this results in a dividend yield of 0.52%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2020 March 2020 December 2019 June 2019
Promoters 46.62 46.62 46.59 46.58
Pledged 0 0 0 0
FII/FPI 23.4 28.51 30.16 31.04
Total DII 13.38 11.8 11.72 13.05
Fin.Insts 3.16 2.99 2.97 2.62
Insurance Co 0 0 0 0
MF 2.36 3.74 4.07 4.88
Others DIIs 7.86 5.07 4.68 5.55
Others 16.59 13.06 11.53 9.35
Total 99.99 99.99 100 100.02

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Glenmark 476.65 -2.89 572.70 168.00 13449.55 6,712.63 1,354.55
Sun Pharma 484.00 -0.59 564.90 315.20 116127.81 12,531.93 3,211.14
Dr Reddys Labs 5051.45 -0.61 5514.65 2497.60 83990.09 11,850.40 2,937.70
Divis Labs 3092.85 -3.96 3388.00 1627.15 82105.45 5,310.57 1,372.71
Cipla 763.85 -2.33 829.00 356.75 61594.25 12,659.15 2,318.17

COMPANY OVERVIEW

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Karvy Computershare Private Ltd.

    • Address

      Plot no. 31-32, GachibowliFinancial DistrictNanakramguda

    • City

      Hyderabad 500032

    • State

      Telangana

    • Tel. No.

      040-23001153

    • Fax No.

    • Email

    • Internet

  • Management

    • Name

      Designation

    • Glenn Saldanha

      Chairman & Managing Director

    • V S Mani

      Executive Director & Global CFO

    • Rajesh V Desai

      Non Executive Director

    • B E Saldanha

      Non Executive Director

    • Bernard Munos

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      Yes

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      Yes

About Glenmark Pharma Ltd.

Glenmark is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Related Searches